Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. We’ve got some nice awards news this morning.
A computer algorithm has achieved a 98% accuracy in predicting different diseases by analyzing the color of the human tongue.
Samuel (Sandy) Aronson, ALM, MA, executive director of IT and AI Solutions for Mass General Brigham Personalized Medicine and senior director of IT and AI
Rise and shine, everyone, another busy day is on the way. Our mascots, for instance, got off to a particularly busy start, having spotted a
The agreement comes following a March 2024 announcement in which the company detailed that it was looking to either spin out or sell off its
Syros still plans to continue the development of tamibarotene in higher-risk myelodysplastic syndromes (HR-MDS) indication, with pivotal complete response data from a Phase III trial
In the evolving landscape of clinical research, the incorporation of cognition into the safety profiles of both CNS and non-CNS indications is becoming increasingly critical.
Otsuka Pharmaceutical has started selling Rejoyn, its Food and Drug Administration cleared prescription app that treats the symptoms of major depressive disorder. And it’s hitting
As I reported on Friday evening, Lykos looks set to appeal the FDA’s decision. The company said it will request a meeting with the agency to ask
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, the FDA’s